Liraglutide and Semaglutide Market Trends

Liraglutide and Semaglutide Market Trends

Obesity is one of the major risk factors contributing to the higher prevalence of diabetes, thus propelling the demand for liraglutide and semaglutide. Obesity leads to increased levels of inflammation and fatty acids that result in insulin resistance causing the risk of type 2 diabetes. Thus, increasing obesity rates globally has created significant demand for effective treatments for weight management and related health conditions. Also, positive results in maintaining blood sugar control, blood pressure and cholesterol levels have significantly demonstrated potential therapeutic applications. Thus, increasing awareness regarding diabetes, obesity related health conditions and favourable government initiatives for preventive healthcare is expected to boost the market growth.